↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
Healthcare PE deployed **$191B** in 2025, but exit velocity lags 34% behind fresh capital—watch November CMS rates and Q1 FDA guidance.
$191 billion
in deal value for 2025
$5.9 billion
acquisition of medical-device manufacturer Integer in August became the…
$1 billion-plus
purchase of PE-backed Tactacam and Rexel's
$1.4 billion
buy of specialty infrastructure distributor GCG from Audax Private…
Healthcare private equity closed $191 billion in deal value for 2025, eclipsing the 2021 watermark and marking the asset class's deepest year-long deployment into life sciences, physician roll-ups, and clinical-AI infrastructure. KKR's $5.9 billion acquisition of medical-device manufacturer Integer in August became the anchor transaction, joined by GTCR's $1 billion-plus purchase of PE-backed Tactacam and Rexel's $1.4 billion buy of specialty infrastructure distributor GCG from Audax Private Equity. The volume reflects two simultaneous bets: that clinical-workflow automation is five years early and that physician-practice consolidation is five years late.
The sector now accounts for 34 percent of global PE deployment by value, up from 22 percent in 2022. Allocators moved $78 billion into AI-enabled diagnostic platforms, remote-monitoring hardware, and payor-data middleware in the first three quarters. Another $63 billion went into physician-practice roll-ups, with orthopedics, dermatology, and ophthalmology absorbing 71 percent of group-practice capital. The remaining $50 billion flowed into device manufacturers and contract-research organizations, where margin compression in legacy product lines met triple-digit growth in GLP-1 ancillary services. August deal volume fell 41 percent month-over-month globally, but healthcare's share climbed to 48 percent of the month's total—KKR's Integer bid alone represented 22 percent of August PE activity.
This matters because the deployment rate is unsustainable without corresponding exit velocity. Healthcare PE funds raised $142 billion in 2024, meaning the 2025 deployment rate exceeded fresh capital by 34 percent. Firms are drawing on dry powder committed in 2021 and 2022, when interest rates sat 340 basis points lower and IPO windows stayed open for 11 consecutive quarters. The current rate-environment mismatch forces exits into three channels: strategic sales to corporate buyers, secondary sales to other PE funds, or dividend recaps that push leverage ratios into the 6.2x–7.1x EBITDA range for top-quartile platforms. The Integer deal carries 5.8x leverage at close, below the healthcare-device median of 6.4x but above KKR's historical 5.2x device average. Physician-practice platforms now run at 7.3x average leverage, up from 5.9x in 2021, as sponsors bet that payor-contract renewals will lift EBITDA faster than interest expense compounds.
Operators and allocators should watch three specific pressure points. First, the CMS physician-fee schedule for 2026, due in November, will reset reimbursement rates for evaluation-and-management codes that represent 53 percent of practice-platform revenue. A 2.8 percent cut, as floated in the proposed rule, compresses cash-flow coverage ratios below 1.15x for platforms carrying 2023-vintage debt. Second, the FDA's final guidance on AI-enabled diagnostic software, expected in Q1 2026, will clarify whether clinical-validation trials are required for retrained models—a decision that adds 18–24 months and $40 million–$80 million to approval timelines. Third, the IPO market for healthcare platforms remains shut; zero PE-backed healthcare companies priced IPOs in Q3 2025, the longest drought since 2009. Strategic buyers absorbed 89 percent of exits in Q3, but corporate cash-on-hand fell 12 percent year-over-year as pharma companies diverted capital into GLP-1 manufacturing capacity.
The market is pricing in a 2027 consolidation event. The $191 billion deployed in 2025 sits against $480 billion in healthcare PE assets under management, meaning funds must exit or refinance 40 percent of portfolio value within 36 months to maintain historical return profiles. Wind-down prep is already visible: GTCR's Tactacam acquisition was a secondary buyout, and Audax's GCG sale to Rexel followed a 31-month hold period, well below the firm's 4.7-year healthcare average. The firms that raised capital in 2024 are deploying into a market where the next vintage's exit buyers have not yet been capitalized.
Branded by POPS4 · proof in 60 seconds
For the principal
The $191B healthcare-PE deployment compresses exit windows; review exposure to 2021–2023 vintage funds carrying 6.5x+ device leverage.
For the operator
Monitor CMS fee-schedule finalization in November and FDA AI-diagnostic guidance in Q1; both reset cash-coverage assumptions for practice platforms.
For the house
Huang Goodman maintains underweight to 2022–2023 healthcare-PE vintages; secondary-market bids on physician-practice platforms remain 18–22% below NAV.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.